Latvia ZVA (State Agency of Medicines) · June 08, 2026

Letter to healthcare professionals: desogestrel and etonogestrel-containing medicines – meningioma risk and risk-reduction measures

Original title: Vēstule veselības aprūpes speciālistiem “Dezogestrelu un etonogestrelu saturošas zāles: meningiomas risks un pasākumi riska samazināšanai”

Safety communication on meningioma risk associated with desogestrel and etonogestrel-containing contraceptive medicines and recommended risk-mitigation actions.

Low obligation Product class Pharmaceuticals Latvia Pharmacovigilance

06.08.2026. Vēstule veselības aprūpes speciālistiem “Dezogestrelu un etonogestrelu saturošas zāles: meningiomas risks un pasākumi riska samazināšanai” Tiecamauditorija Lasīt tālāk Facebook Twitter Google

Dates and deadlines

Applies from

2026-08-06

Read the official source ↗

Published by Latvia ZVA (State Agency of Medicines). HealthSignal links to the original document; the summary above is extracted from the source text.